EcoDrugPlus

Cyclin Dependent Kinase 9

Ensembl ID : ENSSTUG00000016931
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cyclin-Dependent Kinase 1

Ensembl ID : ENSSTUG00000021324
Gene Symbol: LOC115193676
3 Cross references
241 Possible Orthologues:

Cyclin-Dependent Kinase 1-Like

Ensembl ID : ENSSTUG00000049597
Gene Symbol: LOC115153283
3 Cross references
241 Possible Orthologues:

Cyclin-Dependent Kinase 2-Like

Ensembl ID : ENSSTUG00000030963
Gene Symbol: LOC115207965
3 Cross references
196 Possible Orthologues:

Cyclin-Dependent Kinase 4-Like

Ensembl ID : ENSSTUG00000020137
Gene Symbol: LOC115150473
3 Cross references
233 Possible Orthologues:

Cyclin-Dependent Kinase 4-Like

Ensembl ID : ENSSTUG00000030494
Gene Symbol: LOC115207950
3 Cross references
233 Possible Orthologues:

Cyclin-Dependent Kinase 6-Like

Ensembl ID : ENSSTUG00000046426
Gene Symbol: LOC115175534
3 Cross references
194 Possible Orthologues:

Cyclin-Dependent Kinase 6-Like

Ensembl ID : ENSSTUG00000041308
Gene Symbol: LOC115174024
3 Cross references
195 Possible Orthologues:

Cyclin-Dependent-Like Kinase 5

Ensembl ID : ENSSTUG00000011004
Gene Symbol: LOC115157187
3 Cross references
164 Possible Orthologues:

Cyclin-Dependent-Like Kinase 5

Ensembl ID : ENSSTUG00000050067
Gene Symbol: LOC115169592
3 Cross references
162 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1-Like

Ensembl ID : ENSSTUG00000029676
Gene Symbol: LOC115166066
3 Cross references
165 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1-Like

Ensembl ID : ENSSTUG00000039135
Gene Symbol: LOC115205800
3 Cross references
166 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).